A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women
Public ClinicalTrials.gov record NCT02210689. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT02210689
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Actavis Inc.
- Industry
- Enrollment
- 604 participants
Conditions and interventions
Conditions
Interventions
- clindamycin phosphate vaginal cream 2% Drug
- placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2013
- Primary completion
- Sep 30, 2014
- Completion
- Nov 30, 2014
- Last update posted
- Jan 27, 2020
2014
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Akesis Investigator site 5 | Birmingham | Alabama | — | — |
| Akesis Investigator site 12 | La Mesa | California | — | — |
| Akesis investigator site 6 | San Diego | California | — | — |
| Akesis Investigator site 1 | Boynton Beach | Florida | — | — |
| Akesis investigator site 14 | North Miami | Florida | — | — |
| Akesis investigator site 17 | Sanford | Florida | 32771 | — |
| Akesis investigator site 8 | Sunrise | Florida | — | — |
| Akesis Investigator site 10 | West Palm Beach | Florida | — | — |
| Akesis Investigator site 9 | Roswell | Georgia | — | — |
| Akesis Investigator site 15 | Metairie | Louisiana | — | — |
| Akesis investigator site 16 | Lawrenceville | New Jersey | — | — |
| Akesis investigator site 11 | Port Jefferson | New York | — | — |
| Akesis investigator site 13 | Philadelphia | Pennsylvania | — | — |
| Akesis Investigator site 7 | Jackson | Tennessee | — | — |
| Akesis investigator site 18 | Houston | Texas | 77011 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02210689, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 27, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02210689 live on ClinicalTrials.gov.